Authors


Cristina Masella, Eng PhD

Latest:

Healthcare Continuity From Hospital to Territory in Lombardy: TELEMACO Project

The TELEMACO project successfully used telemedicine to establish a healthcare continuity from hospital to territory in remote areas of the Lombardy region of Italy.


Glenn Sterner, PhD

Latest:

A Multistakeholder Effort in Pennsylvania to Improve the Accuracy of Reporting Fatal Drug Overdoses

The authors describe a novel training program for death certifiers in Pennsylvania, which has been designed to specifically focus on some of the main challenges in the death certification process and resulted in a useful model that can potentially be adopted by other states or municipalities.





Mohamed Noureldin, MBBS

Latest:

5-ASA to Sulfasalazine Drug Switch Program in Patients With Ulcerative Colitis

A 5-aminosalicylic acid (5-ASA) drug switch program switching from 5-ASA to sulfasalazine was instituted for insured patients with ulcerative colitis. Unanticipated barriers limited the number of patients who switched, but significant cost savings were still obtained.


Aaron L. Schwartz, PhD

Latest:

Medicaid Managed Care Penetration and Drug Utilization for Patients With Serious Mental Illness

This study examines the relationship between Medicaid managed care penetration within a state and spending on pharmaceuticals for patients with serious mental illnesses.



Edward Sung, BS, BSE

Latest:

Medicare Savings From Conservative Management of Low Back Pain

This instrumental variables analysis estimates that Medicare would realize $362 million in annual savings if all patients with newly diagnosed low back pain were managed conservatively.



Fiona Clement, PhD

Latest:

A Systematic Review of Value-Based Insurance Design in Chronic Diseases

Value-based insurance design for prescription drug coverage increases drug adherence in patients with chronic disease, though their effect on clinical outcomes and health spending remain uncertain.


Daniel C. Malone, RPh, PhD

Latest:

Burden of Alzheimer's Disease and Association With Negative Health Outcomes

Community-based persons with Alzheimer’s disease have a higher risk of fractures, hospitalization, and various comorbidities than persons without the disease.



Traci R. Capesius, MPH

Latest:

The Role of Health Systems in Reducing Tobacco Dependence

Addressing tobacco use is an important health system role. This process evaluation discusses facilitators and barriers to implementing systems changes to improve tobacco treatment delivery.


Salomeh Keyhani, MD, MPH

Latest:

Guideline Concordance of New Statin Prescriptions: Who Got a Statin?

New statin prescriptions at the Veterans Health Administration were reviewed using a cross-sectional study design. Statins were frequently prescribed outside of guideline recommendations.



Anthony M. Louder, PhD, RPh

Latest:

Out-of-Pocket Costs and Prescription Reversals With Oral Linezolid

Associations between out-of-pocket costs and prescription reversals, as well as impact of reversals on rehospitalizations and healthcare costs, were examined among patients prescribed oral linezolid.



Joseph C. Hodges, MD, MBA

Latest:

Cost-Effectiveness Analysis of SBRT Versus IMRT: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate Cancer

Stereotactic body radiation therapy for low- to intermediate-risk prostate cancer has potential cost savings and may improve access to radiation, increase convenience, and boost quality of life.


Robert S. Kirsner, MD, PhD

Latest:

Clinical Evidence for and Cost-Effectiveness of Advanced Cellular Tissue Products for the Treatment of Diabetic Foot Ulcers

An estimated 30 million Americans are living with diabetes. Additionally, 84 million have prediabetes, a condition that will result in type 2 diabetes within 5 years if not properly treated. Long regarded as one of the most prevalent chronic diseases in United States, diabetes is also a leading cause of disability and the seventh-leading cause of death. Less discussed is one of the most common complications of diabetes: diabetic foot ulcers. If not properly treated with standard and adjunctive care, these chronic wounds can lead to permanent disability and premature death.


Jeffrey Teuteberg, MD

Latest:

Benchmarking Health-Related Quality-of-Life Data From a Clinical Setting

Health-related quality-of-life data are often collected during routine clinical care. We present a method to create nationally representative benchmarks for clinical subspecialties.


Luisa De Fendi, BSc

Latest:

Assessment and Potential Determinants of Compliance and Persistence to Antiosteoporosis Therapy in Italy

This analysis of antiosteoporosis therapy shows that 75% of patients have inadequate drug coverage and that adherence is strongly associated with age and administration regimen.


Glenn A. Melnick, PhD

Latest:

Medicare HMO Impact on Utilization at the End of Life

HMOs in California, particularly Kaiser, have developed approaches to end-of-life care that allow them to use far fewer inpatient resources than fee-for-service providers.


Brian W. Bresnahan, PhD

Latest:

Systematic Review of Comparative Effectiveness Data for Oncology Orphan Drugs

This study critically assessed the published clinical and economic evidence supporting oncology orphan drugs marketed in the United States.


Jane E. Weinreb, MD

Latest:

Self-monitoring of Blood Glucose Levels in Patients With Type 2 Diabetes Mellitus Not Taking Insulin: A Meta-analysis

A meta-analysis of 9 RCTs found little benefit in self-monitoring of blood glucose levels on A1C outcomes in patients with diabetes mellitus not taking insulin.



Ming Tai-Seale, PhD, MPH

Latest:

The Human Resource Costs of Implementing Autopend Clinical Decision Support to Improve Health Maintenance

The development and deployment of an autopend functionality within an existing health maintenance system took more than 3 years and cost $201,500 (2013 US$).


Robert M. Rifkin, MD

Latest:

Recommendations for the Role of Clinical Pathways in an Era of Personalized Medicine

We offer recommendations for the development and design of clinical pathways in an effort to establish a set of normative criteria that creates trust and transparency.



AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo